🇨🇦 Canada Country × Condition
breast neoplasms Clinical Trials in Canada
Active clinical trials for breast neoplasms with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇦 Canada
Active Trials in Canada (3)
NCT04608357
Recruiting
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Enrollment
25 pts
Country
🇨🇦 Canada
Sunnybrook Health Sciences Centre
View Trial → NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Enrollment
421 pts
Country
🇨🇦 Canada
Eli Lilly and Company
View Trial → NCT04641247 Phase 2
Recruiting
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Enrollment
30 pts
Country
🇨🇦 Canada
GlaxoSmithKline
View Trial → Frequently Asked Questions
How many breast neoplasms clinical trials are active in Canada?
There are currently 3 active clinical trials for breast neoplasms with sites in Canada, of which 3 are actively recruiting patients.
How can I join a breast neoplasms clinical trial in Canada?
To join a breast neoplasms clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast neoplasms trials in Canada?
Active breast neoplasms trials in Canada span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.